Home › NDC Lookup › Ingredients › Petrolatum › 79974-0203-06
CUREFINI Petrolatum 300 mg/mL Cream, 177.441 mL — NDC 79974-0203-06 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CUREFINI Petrolatum 300 mg/mL Cream, 177.441 mL — NDC 79974-203-06 (Billing 79974-0203-06)

by Miramar Cosmetics, Inc DBA Miramar Lab · 177.441 mL in 1 TUBE

This is a package of 177.441 mL of CUREFINI Petrolatum 300 mg/mL Cream from Miramar Cosmetics, Inc DBA Miramar Lab, marketed since Apr 2023 and currently FDA-listed.

NDC 79974-0203-06
🏷️ FDA NDC (as labeled) 79974-203-06 billing pads the product segment with a zero
This package
Contains177.441 mL Pack sizes3 compare ↓
Product page 79974-0203-02 Also comes in: 59.147 ml 79974-203-02 118.294 ml 79974-203-04
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 79974-203-06 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
79974 labeler · 203 product · 06 package
Package marketed since
Apr 24, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 7997420306 0
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 79974-203-06
Product NDC 79974-203
11-digit billing NDC 79974020306
RxCUI 1043075
UNII 4T6H12BN9U
Application # M016
SPL Set ID 6a2610ca-ca80-451f-8fed-b982443a10b9
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-04-24
Route TOPICAL
Dosage form CREAM
Substance PETROLATUM
Quick answers
  • RxCUI (RxNorm): 1043075
Why two NDCs? The FDA registers this code as 79974-203-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 79974-0203-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

CUREFINI Petrolatum 300 mg/mL Cream is an over-the-counter topical cream containing petrolatum as its active ingredient. Petrolatum is an emollient commonly used in skin care products to help soften and protect the skin by forming a moisture barrier. This product is marketed under FDA's OTC monograph guidelines for skin protectants and moisturizers.

Supplement & herbal interactions

Some supplements/herbs that may interact with Petrolatum — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Petrolatum (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 59.147 ml 118.294 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
79974-0203-02 79974-203-02 Main listing 59.147 mL in 1 TUBE 2023-04-24 — Active
79974-0203-04 79974-203-04 118.294 mL in 1 TUBE 2023-04-24 — Active
79974-0203-06 You're viewing this 177.441 mL in 1 TUBE 2023-04-24 — Active

Pack size FAQ

What quantity is in this package?
This package contains 177.441 mL — 177.441 ml in 1 tube.
How does this package differ from NDC 79974-0203-02?
Both are CUREFINI Petrolatum 300 mg/mL Cream — the drug itself is identical. This page's package is the 177.441 mL one, while NDC 79974-0203-02 is the 59.147 ml package.
What NDC number is used to bill for this package of CUREFINI Petrolatum 300 mg/mL Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Petrolatum 30 g/100g 33992-0498-01 Greenbrier 85 g — — FDA listed —
Petrolatum 30 g/100g 33992-0499-01 Greenbrier 85 g — — FDA listed —
CareALL Creamy Cocoa Butter Petroleum Jelly 30 g/100g 51824-0083-03 New 85 g — — FDA listed —
XtraCare Creamy Petroleum Jelly Cocoa Butter Enriched 59 g/198g 57337-0039-01 Rejoice 198 g — — FDA listed —
XtraCare Creamy Petroleum Jelly Vitamin E enriched 59 g/198g 57337-0040-01 Rejoice 198 g — — FDA listed —
Vaseline Intensive Care Deep Moisture 30 g/100g 64942-1401-01 Conopco 127 g — — FDA listed —
CUREFINI Skin Protection Cream 300 mg/mL 69981-0194-01 Rev 30 ml — — Discontinued —
Curefini Dermal 300 mg/mL 69981-0729-01 Rev 1 bottle — — Discontinued —
Curefini 300 mg/mLthis 79974-0203-06 Miramar 177.441 ml — — FDA listed —
Drs. Pharmacy Creamy Petroleum Jelly 30 g/100g 80489-0901-01 OL 85 g — — FDA listed —
Drs. Pharmacy Creamy Cocoa Butter Petroleum Jelly 30 g/100g 80489-0902-01 OL 85 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Apr 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII 09FUA47KNA
    Cetearyl glucoside is a plant-derived surfactant made from vegetable oils and glucose. It helps oils and water mix together in creams and lotions, and can also soften and smooth the skin feel of the product.
  • UNII 58B69Q84JO
    A plant-derived emulsifier made from olive oil and fatty alcohols. It helps blend oil and water ingredients together and stabilizes the product's texture in creams, lotions, and similar formulations.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII FGL3685T2X
    Chamomile is a plant extract used in medications as a flavoring agent and for its mild soothing properties in formulations. It helps improve taste and aroma of the medicine.
  • UNII 60F80Z61A9
    A fragrant plant oil extracted from chamomile flowers. It's used as a flavoring agent and fragrance in medicines to improve taste and smell, making the product more pleasant to take.
  • UNII 5OCF3O11KX
    A plant-derived surfactant made from coconut oil. It helps mix oil and water ingredients together in the formulation and can improve how the medicine spreads or feels on the skin.
  • UNII BBL281NWFG
    Cod liver oil is a natural oil derived from fish liver that serves as a source of omega-3 fatty acids and vitamins A and D in formulations. It's used as a nutrient supplement ingredient and as an emollient to help soften and smooth the product.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII MDL271E3GR
    Sorbitan olivate is an emulsifier derived from sorbitol and olive oil. It helps blend water and oil ingredients together to maintain consistent texture and appearance throughout the medicine.
  • UNII 3W1JG795YI
    Sunflower oil is a natural vegetable oil derived from sunflower seeds. It serves as a solvent, lubricant, and carrier in medicines, helping dissolve active ingredients and improve how the medication flows and absorbs in the body.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 2ZA36H0S2V
    Beeswax is a natural wax produced by honeybees. In medicines, it works as a coating agent and thickener to control how fast the drug dissolves and improve the product's texture and appearance.

14 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAqua (Deionized Water), Beeswax, Cetearyl Alcohol, Cetearyl Olivate, Cetearyl Glucoside, Chamomilla Recutitta (Chamomile) Extract, Chamomilla Recutitta (Chamomile) Oil, Cocamidopropyl Betaine, Ethylhexylglycerin, Gadi Lecur (Cod Liver) Oil, Helianthus Annuus (Sunflower) Seed Oil, Phenoxyethanol, Sorbitan Olivate, Tocopheryl Acetate (Vitamin E).

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMiramar Cosmetics, Inc DBA Miramar Lab
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code79974
First marketedApr 2023
Product typeHuman Otc Drug
Portfolio7 products on file

More NDCs from Miramar Cosmetics, Inc DBA Miramar Lab labeler code 79974

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 32 words ▾

USES: • For temporary protection of minor cuts, scrapes and burns. • For temporary protection of cracked and chapped skin. • Helps protect from the drying effects of wind and cold weather.

⏱️ Dosage and Administration 25 words ▾

Directions: Apply daily over the affected area, with soft massages to ease absorption. Repeat application as many times as needed to keep skin permanently moisturized.

⚠️ Warnings 45 words ▾

WARNINGS: For external use only • Avoid contact with eyes. • If symptoms persist for more than seven days, discontinue use and consult physician. • Keep out of reach of children. If swallowed, consult physician. • Do not use if tamper evident seal is broken.

📦 Storage and Handling 17 words ▾

Other information: • Store at room temperature. • Do not use if tamper evident seal is broken.

🧪 Active Ingredient 3 words ▾

Active Ingredient: Petrolatum.............30.00%

🧪 Inactive Ingredients 40 words ▾

Inactive Ingredients: Aqua (Deionized Water), Beeswax, Cetearyl Alcohol, Cetearyl Olivate, Cetearyl Glucoside, Chamomilla Recutitta (Chamomile) Extract, Chamomilla Recutitta (Chamomile) Oil, Cocamidopropyl Betaine, Ethylhexylglycerin, Gadi Lecur (Cod Liver) Oil, Helianthus Annuus (Sunflower) Seed Oil, Phenoxyethanol, Sorbitan Olivate, Tocopheryl Acetate (Vitamin E).

🎯 Purpose 3 words ▾

Purpose Skin Protectant

📄 Keep Out of Reach of Children 21 words ▾

• Keep out of reach of children. If swallowed, consult physician. • Do not use if tamper evident seal is broken.

📄 Questions or Comments 4 words ▾

Questions? (M-F) (9-5pm EST)

📄 Package Label / Principal Display Panel 2 words ▾

Packaging cream203

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for CUREFINI (this brand).

Top reported reactions

Rash45
Pneumonia31
Pruritus31
Cellulitis29
Dyspnoea24
Urinary Tract Infection24
Dizziness23

Age at onset

Neonate5
Infant3
Child9
Adolescent3
Adult57
Elderly59

Reporter sex

435 reports
Male · 55%
Female · 45%

Serious outcomes

Hospitalization260
Death72
Life-threatening49
Disabling8
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 61 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Miramar Cosmetics, Inc DBA Miramar Lab. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 59.147 ml (79974-0203-02), 118.294 ml (79974-0203-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Miramar Cosmetics, Inc DBA Miramar Lab is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 79974-0202-01 · Miramar 79974-0205-05 · Miramar →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.